Fountain presents testosterone care as a package: medical evaluation, treatment when appropriate, testing, and continuing support. That can make the shopping experience easier to follow. The detail worth slowing down for is the calendar. Its current plans use weeks, which do not match ordinary monthly budgeting.
We reviewed Fountain’s public TRT page on September 23, 2026. This is a review of published information, not an account of receiving care. Below, we separate the advertised package from the prescription, pharmacy, and payment details a prospective patient still needs in writing.
KEEP IN MIND
The useful bits.
- Four-week billing is different from monthly billing.
- Verify the actual medicine and pharmacy before comparing formulations.
- Confirm home collection, extra tests, and renewal terms in writing.
What the advertised prices actually cover
The Starter plan is advertised at $199 every four weeks. Standard is $499 every 12 weeks, and Pro is $1,799 every 48 weeks. Those are three different commitments. A four-week charge happens more often than a calendar-month charge; 48 weeks also finishes before a full 52-week year.
For a simple illustration, 13 four-week periods at $199 equal $2,587 over 52 weeks. That is arithmetic using the published Starter rate, not a personalized treatment estimate. Before choosing a longer term, ask about the amount charged today, renewal timing, cancellation, and what happens to unused treatment if a clinician changes the plan.
Sources: Fountain: TRT options and four-week, 12-week, and 48-week billing
Put laboratory costs beside the plan price
The public offer describes laboratory testing and medical care as part of the package. Fountain also describes local Labcorp collection and an upgraded home collection option. The home option should not be assumed to cost the same. We did not verify a single upgrade fee applicable to every patient.
Ask which initial tests and repeat tests are included, where collection happens, and who pays for additional testing after an unexpected result. It is useful to know whether a repeat morning sample is arranged before treatment when necessary. Endocrine Society guidance bases diagnosis on compatible symptoms and consistently low testosterone, with repeat morning testing to confirm it.
Sources: Fountain: TRT options and four-week, 12-week, and 48-week billing · Endocrine Society: testosterone therapy clinical guidance
A video visit needs a practical follow-up plan
Fountain describes a face-to-face video evaluation and continuing access to its care team. We have not measured response times or tested the service. Before paying, ask who reviews results, how the clinician explains an abnormal value, and what to do if the next refill arrives before a planned review.
Bring an accurate list of prescriptions, supplements, prior laboratory results, and any current testosterone use. For someone moving from another clinic, an orderly transfer is more useful than a promised quick start. Our provider-switching checklist covers records and continuity questions without telling you to change a prescribed regimen yourself.
Sources: Fountain: TRT options and four-week, 12-week, and 48-week billing · Endocrine Society: testosterone therapy clinical guidance
A topical option changes the household routine
A cream can sound simpler than an injection, but it still needs instructions specific to the dispensed product. Ask about application location, hand washing, skin contact, storage, and what to do if another person touches a treated area. The answers should come from the prescriber and pharmacy for that exact preparation.
FDA-approved AndroGel has explicit secondary-exposure precautions. That label is a useful example of why household contact matters, not an instruction sheet for every cream. If you regularly care for grandchildren or help a partner with dressing, describe that routine during the consultation so the clinician can discuss whether a topical route is workable.
Sources: Fountain: TRT options and four-week, 12-week, and 48-week billing · DailyMed: AndroGel 1.62% prescribing information
Convenience does not settle clinical suitability
A plan that fits your budget may still be medically unsuitable. Ask how the practice evaluates the cause of low testosterone and monitors treatment, including blood pressure and blood counts when indicated. FDA’s labeling changes removed certain cardiovascular boxed-warning language while adding or reinforcing blood-pressure information; they did not establish that all testosterone treatment is risk free.
Future fertility also belongs in the first conversation, even if it is not an immediate goal. Exogenous testosterone can affect sperm production. An attractive list of included extras does not establish that an additional drug is necessary. Ask the clinician to explain the reason, risks, and separate cost of each proposed medicine.
Sources: Endocrine Society: testosterone therapy clinical guidance · FDA: 2025 testosterone labeling and blood pressure changes
Who should keep Fountain on a shortlist
Fountain is worth examining if you want to compare a packaged service with several possible treatment routes and can budget by its actual billing periods. It remains necessary to confirm state access, the exact prescription, and all payment terms. We cannot infer patient satisfaction or clinical results from the provider’s marketing page.
Use Fountain versus Henry Meds to compare the published offers on a common timeline. If route selection is your main concern, start with our medication-route shortlist. The best next step is a written explanation of the care and bill you would personally receive.
Sources: Fountain: TRT options and four-week, 12-week, and 48-week billing · Henry Meds: TRT plans, costs, eligibility, and cancellation FAQ
Sources you can check
Provider pages describe commercial offers. Medical references provide context. Checked September 23, 2026; prices and availability can change.
- Fountain: TRT options and four-week, 12-week, and 48-week billing
- FDA: understanding the risks of compounded drugs
- Endocrine Society: testosterone therapy clinical guidance
- DailyMed: AndroGel 1.62% prescribing information
- FDA: 2025 testosterone labeling and blood pressure changes
- Henry Meds: TRT plans, costs, eligibility, and cancellation FAQ
Educational information for adults, not a diagnosis or treatment plan. Discuss symptoms and treatment decisions with a licensed clinician. Do not change a prescription based on this article.